item management s discussion and analysis of financial condition and results of operations except for historical information  statements relating to the company s plan  objectives and future performance are forward looking statements within the meaning of the private securities litigation reform act of such statements are based on management s current expectations 
because of various risks and uncertainties  actual strategies and results in future periods may differ materially from those currently expected 
the discussion set forth below analyzes certain factors and trends related to the financial results for each of the three years ended april   and this discussion should be read in conjunction with the consolidated financial statements and notes to the consolidated financial statements 
background the company was incorporated in delaware in and initially provided medical advertising and marketing services in the united states  primarily to ophthalmologists 
by  the company had shifted its strategic emphasis to the emerging ophthalmic technology based on the use of excimer lasers for prk and acquired an excimer laser for use in a clinical center as part of clinical trials with respect to the safety and efficacy of prk 
the company then determined that fda approval for prk in the us would take longer than originally anticipated and therefore decided to enter international markets for excimer laser surgery where regulatory restrictions were less prohibitive 
between late and april  the company acquired four commercial excimer laser centers in canada  developed the first mobilexcimer unit and purchased fourteen european excimer lasers 
the first prk procedure on a mobilexcimer system was performed in ontario  canada in september in anticipation of the fda s approval of the excimer laser to perform prk procedures  in december the company restated its agreement with columbia hca healthcare corporation columbia pursuant to which the company became the primary provider of excimer lasers to columbia s ambulatory surgery centers 
in addition  by the fall of  the company extended testing of its mobilexcimer system to england  opened two european centers including a company owned center in london  acquired an additional mobilexcimer unit and entered into an agreement with dr 
richard lindstrom to serve as the company s medical director 
in august  the company acquired an excimer laser access provider  vision correction  inc  for  of common stock 
in october and march  the fda approved the use of the excimer lasers manufactured by summit and visx  respectively  for performing prk procedures for low to moderate myopia  making it possible for the company to begin providing ophthalmologists access to excimer lasers in the united states 
during april  the company purchased assets from a former competitor to expand its european operations for a purchase price of approximately  including cash and assumed liabilities 
in and  the company helped train hundreds of us ophthalmologists in refractive eye surgery  developed its capacity to provide mobile services to over one hundred twenty domestic locations  expanded its international mobile services  closed five unprofitable international fixed sites  established eight domestic fixed sites  developed comprehensive practice development and telemarketing services to help domestic ophthalmologists increase their profits and procedure volume and  during the quarter ended april   succeeded in reaching profitability 
in addition  when visx obtained approval to treat astigmatism and higher levels of myopia  the number of patients able to be treated increased 
results of operations fiscal year ended april  compared to fiscal year ended april  during the year ended april   the company continued to develop the us market by targeting ophthalmologists in medium sized markets 
these practices were primarily served with the newly developed roll on roll off mobile system 
revenues 
total revenues increased to  for the year ended april  from  for the year ended april   or an increase of 
the increase in revenues is attributable to a  increase in domestic revenues partially offset by a  decrease in european and canadian revenues 
the increase in domestic revenues is attributable to the increased number of us lasers in operation and procedures performed on each laser in the us the decrease in european and canadian revenues is attributable to closing certain unprofitable fixed sites and converting most of them to mobile sites during the year 
costs of revenues gross profit 
costs of revenues increased to  for the year ended april  from  for the year ended april  this increase was primarily due to an increase of  in total domestic per procedure royalties  an increase of  in mobile laser operator salaries and travel costs  an increase of  in depreciation  and an increase of  in professional medical services 
total gross profit increased to  for the year ended april  from  for the year ended april  the variable gross profit  excluding depreciation  increased to  from  primarily due to higher volumes of procedures at an increased number of sites 
operating expenses 
selling  general and administrative expenses decreased to  for the year ended april  from  for the year ended april  primarily due to the non cash impairment charge of million recorded in the fourth quarter of fiscal decreases in general and administrative expenses of  and selling and marketing expenses of  were partially offset by increases in salaries and related expenses of  and depreciation and amortization of  loss from operations 
the loss from operations decreased to  for the year ended april  from  for the year ended april  primarily due to the gross profit on the increased us revenues  the decreased non cash impairment charges of million and the reduced operating loss from the international operations where unprofitable fixed sites were closed and replaced with mobile services 
other income expense 
other income expense increased to a net expense of  for the year ended april  from a net expense of  for the year ended april  this increase was primarily due to an increase of  in interest expense 
fiscal year ended april  compared to fiscal year ended april  during the year ended april   the company focused upon the development of the us market 
during the last quarter of fiscal the company began aggressively pursuing its mobile laser strategy in the us by redeploying several of its fixed site lasers utilizing its newly developed roll on roll off strategy 
revenues 
total revenues increased to  for the year ended april  from  for the year ended april   or an increase of 
the increase in revenues is attributable to a  increase in us revenues and a  increase in european revenues 
the increase in us revenues for the laservision centers division is attributable primarily to the increased number of lasers in operation and procedures performed on each laser in the us the increase in european revenues is attributable to the increased procedures from the solihull and edinburgh centers acquired in the new image acquisition and increased procedures performed on the mobilexcimer 
costs of revenues gross profit loss 
cost of revenues increased to  for the year ended april  from  for the year ended april  this increase was primarily due to an increase in depreciation to  from  in these respective periods due to the increased inventory of lasers and other medical equipment 
excluding laser and medical equipment depreciation  all other costs of revenues increased by  this increase  when combined with the revenue increase  resulted in these other costs of revenues decreasing from of total revenues for the year ended april  to of total revenues for the year ended april  this  increase was primarily due to an increase of  in total domestic per procedure royalties   in professional medical services and  in gas costs on higher volumes of prk procedures and new centers 
total gross profit increased to a profit of  for the year ended april  from a loss of  for the year ended april  the variable gross profit  excluding depreciation  increased to  from  primarily due to higher volumes of prk procedures and centers 
operating expenses 
selling  general and administrative expenses increased to  for the year ended april  from  for the year ended april  due to an increase of  in general and administrative expenses  an increase of  in salaries and related expenses  and increase of  in depreciation and amortization  and an increase of  in selling and marketing expenses 
these increases were partially offset by a decrease in non cash impairment charges of  loss from operations 
the domestic loss from operations increased to  for the year ended april  from  for the year ended april  due to a million write down of lasers and related equipment  a million increase in the loss from us laser operations  and a  increase in payroll 
the canadian loss from operations decreased to  for the year ended april  from  for the year ended april  primarily due to a decrease of  in the write down of lasers and related medical equipment  and a decrease in the loss from operations of  in the st 
catharines center which became a mobilexcimer site 
the european loss from operations decreased to  for the year ended april  from  for the year ended april  due to a decrease in the write down of lasers and related medical equipment of other income expense 
other income expense decreased to a net expense of  during the year ended april  from a net income of  during the year ended april  this decrease was due to a  decrease in interest income and other  a  increase in interest expense and a  decrease in the minority interest in the net loss of a subsidiary 
inflation the company s operations have not been  nor are they expected to be  materially affected by inflation 
liquidity and capital resources since the completion of its initial public offering in april  the company s primary sources of liquidity have consisted of financing from the sale of common stock and convertible preferred stock  revenues from laser access and marketing services provided to ophthalmic physicians  leases and notes payable 
at april   the company had  of cash and cash equivalents compared with  at april  at april   the company had working capital of  compared with working capital of  at april  the ratio of current assets to current liabilities at april  was to one  compared to to one at april  cash flows from operating activities 
net cash provided by operating activities was  for fiscal compared to net cash used in operating activities of  and  for fiscal and  respectively 
the cash flows provided by operating activities during fiscal primarily represent the net loss incurred in this period less depreciation and amortization and an increase in accounts payable and accruals  offset by an increase in accounts receivable and inventory 
the cash flows used for operating activities during fiscal primarily represent the net loss incurred in this period less depreciation  amortization and fixed asset impairment and an increase in accounts payable  offset by an increase in accounts receivable 
the cash flows used for operating activities in fiscal primarily represent the net loss incurred less depreciation  amortization and fixed asset impairment 
cash flows from investing activities 
net cash used for investing activities was  during fiscal and  and  for fiscal and  respectively  and was primarily due to the acquisition of equipment  equipment deposits and acquisitions 
cash flows from financing activities 
net cash provided by financing activities during fiscal was  and was primarily due to proceeds from a private offering of preferred stock  notes payable  and exercise of stock options and warrants offset by the repayment of notes payable and capitalized lease payments 
net cash provided by financing activities during fiscal was  and was primarily due to proceeds received from notes payable and the exercise of stock options offset by the repayment of certain notes payable and capitalized lease obligations 
net cash provided by financing activities for fiscal was  and was primarily due to proceeds received from a private placement of the company s convertible preferred stock with a provision for mandatory redemption in and the exercise of warrants 
the company anticipates that its current cash and cash equivalents will be sufficient to fund operating expenses for the next two years  including any capital expenditures not externally financed 
the company expects to continue to fund future operations from existing cash and cash equivalents  revenues received from providing laser access and market services  the exercise of stock options and warrants and external financing as required 
there can be no assurance that capital will be available when needed or  if available  that the terms for obtaining such funds will be favorable to the company 
at april   the company has net operating loss carryforwards of approximately million available to offset future taxable income  expiring through the company has recorded a deferred tax asset of approximately million with offsetting valuation allowances at april  for purposes of recording deferred tax assets  no future taxable income is assumed given the results of operations of the company to date 
the amount of the valuation allowance could be reduced in the near term if estimates of future taxable income are increased 
new accounting standards in march  the financial standards board issued a statement of financial accounting standards no 
 earnings per share fas which requires public entities to present both basic and diluted earnings per share amounts on the face of their financial statements  replacing the former calculations of primary and fully diluted earnings per share 
the company adopted fas effective with its fiscal third quarter 
in june  the fasb issued fas  disclosures about segments of an enterprise and related information  effective for periods beginning after december  fas supersedes fas  financial reporting for segments of a business enterprise 
fas establishes standards for the way public business enterprises report financial and descriptive information about the reportable operating segments in their financial statements 
generally  financial information is required to be reported on the basis that is used internally for evaluating segment performance and deciding how to allocate resources to segments 
the company continues to evaluate the provisions of fas to determine the impact of the revised disclosure requirements on its fiscal financial statements 
year compliance the company is currently working to resolve the potential impact of the year on the processing of date sensitive information by the company s computerized information systems 
the year problem is the result of computer programs being written using two digits rather than four to define the applicable year 
any of the company s programs that have time sensitive software may recognize a date using as the year rather than the year  which could result in miscalculations or system failures 
the company s new accounting and management reporting system is year compliant 
the laser manufacturer of the company s lasers has advised the company that the lasers will operate in the year and that the manufacturer is working to ensure that all documentation from the lasers computers will be reported properly in the year at this stage in the assessment process  the company does not believe that the year issue will pose significant operational problems for its business or products or have a material adverse impact on the company s financial position  results of operations or cash flows in future periods 
there can be no assurance that operating problems or expenses related to the year issue will not arise with the company s computer systems and software or that the company s customers or suppliers will be able to resolve their year issues in a timely manner 
accordingly  the company plans to devote the necessary resources to resolve all significant year issues in a timely manner 

